Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) Revenue (2016 - 2025)

Historic Revenue for Abeona Therapeutics (ABEO) over the last 13 years, with Q2 2025 value amounting to $400000.0.

  • Abeona Therapeutics' Revenue changed N/A to $400000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $400000.0, marking a year-over-year change of. This contributed to the annual value of $3.5 million for FY2023, which is 14752.48% up from last year.
  • As of Q2 2025, Abeona Therapeutics' Revenue stood at $400000.0.
  • In the past 5 years, Abeona Therapeutics' Revenue ranged from a high of $3.5 million in Q2 2023 and a low of -$1.5 million during Q2 2021
  • For the 4-year period, Abeona Therapeutics' Revenue averaged around $185555.6, with its median value being $68000.0 (2022).
  • Per our database at Business Quant, Abeona Therapeutics' Revenue crashed by 13666.67% in 2021 and then soared by 25000.0% in 2023.
  • Quarter analysis of 4 years shows Abeona Therapeutics' Revenue stood at -$48000.0 in 2021, then skyrocketed by 241.67% to $68000.0 in 2022, then soared by 5047.06% to $3.5 million in 2023, then plummeted by 88.57% to $400000.0 in 2025.
  • Its Revenue was $400000.0 in Q2 2025, compared to $3.5 million in Q2 2023 and $68000.0 in Q4 2022.